Michael Vannier to Pancreatic Neoplasms
This is a "connection" page, showing publications Michael Vannier has written about Pancreatic Neoplasms.
Connection Strength
0.123
-
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Pancreas. 2016 Mar; 45(3):370-5.
Score: 0.088
-
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc. 2002 Dec; 56(6):803-9.
Score: 0.035